Boston, October 15, 2026 — Colait today announced thelaunch of a structured clinical opinion data collection initiative inneuroscience, marking the company's first large-scale therapeutic area studyand a significant expansion of what will become the first nationally representativequalitative clinical opinion dataset across therapy areas.
The announcement comes as industry leaders gather in Bostonthis week to examine the future of scientific innovation and the growingimperative to rebuild trust in science; two conversations that sit at the heartof what Colait is building.
Real-world evidence has transformed how the pharmaceuticaland life sciences industries understand disease, treatment patterns, andpatient outcomes. Claims data, EHR records, and registry data have made it possibleto study populations at scale. Yet one critical source of intelligence remainslargely uncaptured: what clinicians actually think, observe, and believe in thecontext of their daily practice.
"Neuroscience is one of the most complex and rapidly evolvingareas in medicine, and the gap between what the data shows and what cliniciansare experiencing in practice can be significant," said Colette Balaam, CEOof Colait. "This initiative is designed to close that gap and todemonstrate that clinical opinion, collected at scale and structured foranalysis, belongs in the same conversation as any other form of real-worldevidence."
Colait's Outreach Agent conducts structured AI-moderatedinterviews with clinicians and patients across geographies and specialtiessimultaneously, producing analysis-ready findings from the moment fieldingcloses.
About Colait
Colait is dedicated to amplifying the voices that shapehealthcare. Colait’s agentic AI platform embeds validated agents directly intothe workflows of pharmaceutical, biotech, and medtech organizations, poweringcommercial, medical affairs, and market access functions at scale. Through itsown sponsored research initiatives, Colait operates its platform to build anindependent, proprietary dataset of structured clinical opinion. Colaittransforms real-world experiences into actionable understanding that helpsadvance knowledge, support innovation, and contribute to better outcomes forpatients worldwide.